Back to top
more

TransEnterix, Inc. (TRXC)

(Delayed Data from AMEX)

$2.06 USD

2.06
1,258,013

+0.05 (2.49%)

Updated May 3, 2019 04:00 PM ET

After-Market: $2.05 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Key Factors to Know Ahead of TransEnterix (TRXC) Q4 Earnings

by Zacks Equity Research

TransEnterix (TRXC) is anticipated to witness robust top-line growth in Q4 on the back of multiple product developments.

Are Options Traders Betting on a Big Move in TransEnterix (TRXC) Stock?

by Zacks Equity Research

Investors need to pay close attention to TransEnterix (TRXC) stock based on the movements in the options market lately.

TransEnterix (TRXC) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

TransEnterix (TRXC) delivered earnings and revenue surprises of 14.29% and 6.65%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Will New Products Drive TransEnterix's (TRXC) Q3 Earnings?

by Zacks Equity Research

Among the recent developments, in the third quarter, TransEnterixs (TRXC) gains an FDA approval for its additional 5 millimeter Senhance System instruments.

TransEnterix (TRXC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

TransEnterix (TRXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TransEnterix's MST Medical Buyout to Boost Senhance Platform

by Zacks Equity Research

TransEnterix (TRXC) acquires Israel-based MST Medical, which will boost surgeons' effectiveness and make procedures quick and error-free.

    TransEnterix (TRXC) Reports Q2 Loss, Tops Revenue Estimates

    by Zacks Equity Research

    TransEnterix (TRXC) delivered earnings and revenue surprises of 0.00% and 3.05%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

      Implied Volatility Surging for TransEnterix (TRXC) Stock Options

      by Zacks Equity Research

      TransEnterix (TRXC) needs investors to pay close attention to the stock based on moves in the options market lately.

        TransEnterix (TRXC) in Focus: Stock Moves 7% Higher

        by Zacks Equity Research

        TransEnterix (TRXC) was a big mover last session, as the company saw its shares rise nearly 7% on the day amid huge volumes.

          Sanghamitra Saha headshot

          Top and Flop Stocks of an Eventful May

          by Sanghamitra Saha

          These stocks outperformed/underperformed in the month of May.

            Options Traders Expect Huge Moves in TransEnterix (TRXC) Stock

            by Zacks Equity Research

            TransEnterix (TRXC) needs investors to pay close attention to the stock based on moves in the options market lately.

              TransEnterix (TRXC) Soars: Stock Adds 14.2% in Session

              by Zacks Equity Research

              TransEnterix (TRXC) saw a big move last session, as its shares jumped more than 14% on the day, amid huge volumes.

                TransEnterix & GBIL Ink Deal to Commercialize SurgiBot System

                by Zacks Equity Research

                TransEnterix (TRXC) to retain distribution rights of SurgiBot System outside China.

                  TransEnterix (TRXC) Posts In-Line Loss in Q3, Sales Fall Y/Y

                  by Zacks Equity Research

                  TransEnterix's (TRXC) reports unimpressive Q3 results, thanks to the constriction of deferred service revenues.

                    Are Options Traders Betting on a Big Move in TransEnterix (TRXC) Stock?

                    by Zacks Equity Research

                    Investors in TransEnterix (TRXC) need to pay close attention to the stock based on moves in the options market lately.

                      TransEnterix (TRXC) Soars: Stock Adds 12.7% in Session

                      by Zacks Equity Research

                      TransEnterix (TRXC) saw a big move last session, as its shares jumped nearly 13% on the day, amid huge volumes.

                        TransEnterix Senhance Surgical Robotic System Wins FDA Nod

                        by Zacks Equity Research

                        TransEnterix (TRXC) works on expanding in robotic surgery consistently.

                          TransEntrix Progresses Toward FDA Approval for Senhance

                          by Zacks Equity Research

                          TransEnterix's (TRXC) gradual progress toward FDA's approval for Senhance Surgical Robotic System will boost its presence in the lucrative U.S. market.

                            TransEnterix Sells Surgery System to Japanese University

                            by Zacks Equity Research

                            TransEnterix, Inc. (TRXC), a global medical technology company, recently announced that it has sold a Senhance Robotic Surgery System to a Japanese customer.

                              TransEnterix (TRXC) Reports Wider-than-Expected Loss in Q1

                              by Zacks Equity Research

                              TransEnterix, Inc. (TRXC) reported a loss of 13 cents per share in the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 12 cents.

                                TransEnterix (TRXC) Reports Wider-Than-Expected Loss in Q4

                                by Zacks Equity Research

                                TransEnterix, Inc. (TRXC) reported a loss of 12 cents per share in the fourth quarter of 2016, wider than the Zacks Consensus Estimate of a loss of 11 cents.

                                  TransEnterix (TRXC) Opens New Surgical Robotics Facility

                                  by Zacks Equity Research

                                  TransEnterix (TRXC) announced that it would open a new surgical robotics facility in Milan, Italy.

                                    4 Medical Instrument Stocks Poised for Earnings Beats in Q2

                                    by Zacks Equity Research

                                    Rising demand for better healthcare at an affordable cost will be a key growth driver for medical instrument suppliers in 2015.